Executive Management

• Healthcare Professionals
•  
• Patients
•  
• Investors
•  
• Media
•  
• R&D
•  
• Jobs
•  
• Sustainability
•  
• About us
•  

• Novo Nordisk in brief
• Novo Nordisk way of management
• Management
• Corporate governance
  • Governance model
  • Shareholder Rights
  • Novo Nordisk Foundation
  • General meetings and Shareholders meeting
  • Board of Directors
  • Chairmanship and board committees
  • Audit Committee
  • Executive Management
  • Remuneration policy
  • Self-assessment
  • Risk management
  • Internal control
  • Assurance
  • Audit
  • Benchmark 2007
  • Codes and practices
• Global offices
• Changing diabetes
• Improving haemophilia
• Novo Nordisk youth panel
• Download centre
• Contact us

• Rate this page
• Send to a friend
• Print

Executive Management

Executive Management is responsible for the day-to-day management of the company. It consists of the president and CEO, and four other executives. Executive Management’s responsibilities include organisation of the company as well as allocation of resources, determination and implementation of strategies and policies, direction-setting and ensuring timely reporting and provision of information to the Board and the stakeholders of Novo Nordisk. Executive Management is also responsible for oversight, implementation and audit of environmental, social and related policies.

Executive Management meets regularly and at least once a month.

Employment of executives

The Board appoints Executive Management and determines its remuneration.

The Chairmanship reviews the performance of the executives. As part of the Organisational Audit process, the Chairmanship identifies successors to executives and presents the names of such candidates to the Board for approval.

Executive Committees

The Executive Management has established a number of executive committees to assist or implement Executive Management's decisions. Such committees include Development Portfolio Committee overseeing, prioritising, and resourcing development projects from an overall portfolio perspective, Environment & Bioethics Committee identifying, developing and managing environmental and bioethical issues and strategies, and Disclosure Committee supervising the reliability of Novo Nordisk's reporting.

Back to top